Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02908464 · ClinicalTrials.gov registry record · NA
Prevention of Early Postoperative Decline
A NA study of Delirium and Postoperative Cognitive Dysfunction, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT02908464: Completed NA study of Delirium and Postoperative Cognitive Dysfunction, sponsored by Beth Israel Deaconess Medical Center.
NCT02908464 is a NA study of Delirium and Postoperative Cognitive Dysfunction that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 45 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02908464, a NA study of Delirium and Postoperative Cognitive Dysfunction, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to determine whether using a brain training program in the time leading up to as well as after heart surgery will reduce confusion and cognitive loss that can occur after surgery.
Primary Outcome
Feasibility will be partly determined by evaluating enrollment. Enrolling \>50% of eligible patients is the target.
Conditions Studied
Interventions
- DEVICE Lumosity
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-09 |
| Phase | NA |
What the finished NCT02908464 record still lists
NCT02908464 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Lumosity is the first listed.
NCT02908464 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02908464 about?
NCT02908464 is a clinical study titled "Prevention of Early Postoperative Decline". The purpose of this trial is to determine whether using a brain training program in the time leading up to as well as after heart surgery will reduce confusion and cognitive loss that can occur after surgery.
What is the current status of trial NCT02908464?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-11. Estimated completion is 2019-09.
What conditions does trial NCT02908464 study?
This clinical trial studies the following conditions: Delirium, Postoperative Cognitive Dysfunction.
What interventions are being tested in trial NCT02908464?
The interventions under investigation include: Lumosity (DEVICE).
Who is sponsoring clinical trial NCT02908464?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02908464 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02908464's enrollment target sits among peer trials
45 53rd of 62 higher than 10 of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia